🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jennifer M. Specht

University of Washington

ORCID: 0000-0003-1484-2113

Also affiliated with University of Washington Medical Center, Fred Hutch Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.742Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772
Top 27%
0.742DataRank
Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Papers

Driven by 12 papers — median percentile 73. Top paper: “Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030”.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology(2023)10.1016/j.annonc.2023.08.004
N/A
1.7DataRank · unranked
58 citations

Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade

Cancer Cell(2020)10.1016/j.ccell.2020.11.005
N/A
0.874DataRank · unranked
338 citations

Scott N. Furlan, Carla A. Jaeger-Ruckstuhl, Megha Sarvothama, Carolina Berger, Kimberly S. Smythe +15 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772
Top 27%
0.742DataRank
Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer

Breast Cancer Research(2023)10.1186/s13058-023-01722-4
N/A
0.727DataRank · unranked
14 citations

Lanell M. Peterson, Isaac Jenkins, Alena Novakova-Jiresova, Hannah M. Linden, Julie R. Gralow +6 more

Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status

Cancer(2023)10.1002/cncr.34679
N/A
0.586DataRank · unranked
12 citations

Laura Ichikawa, Rebecca A. Hubbard, Diana S.M. Buist, Erin J. Aiello Bowles, Louise M. Henderson +6 more

Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting

Frontiers in Oncology(2024)10.3389/fonc.2024.1395502
N/A
0.241DataRank · unranked
4 citations

Xin Li, Michael Hirano, Assim Saad Eddin, Jeong Youn Lim, Debosmita Biswas +20 more

qPCR assay for detection of Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Elements from CAR-T and TCR-T cells in fresh and formalin-fixed tissue

PLoS ONE(2024)10.1371/journal.pone.0303057
N/A
0DataRank · unranked
0 citations

Graeme C. Black, Marie Bleakley, Denise Buenrostro, Aude G. Chapuis, Alexandre V. Hirayama +12 more

Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer

Breast Cancer Research(2025)10.1186/s13058-025-01975-1
N/A
0DataRank · unranked
1 citations

Lanell M. Peterson, Jennifer M. Specht, David A. Mankoff, Mark Muzi, Delphine L. Chen +5 more

Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1042
N/A
0DataRank · unranked
1 citations

Lanell M. Peterson, David A. Mankoff, Mark Muzi, Delphine L. Chen, Shaveta Vinayak +4 more

ACR Appropriateness Criteria® Imaging of Invasive Breast Cancer

UNC Libraries(2025)10.17615/1tw5-dd21
N/A
0DataRank · unranked
0 citations

Priscilla J. Slanetz, Basak E Dogan, John R. Scheel, Alana A. Lewin, Gary A. Ulaner +12 more

Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization

Journal of the American College of Radiology(2020)10.1016/j.jacr.2019.12.020
N/A
0DataRank · unranked
10 citations

Laura Ichikawa, Karen J. Wernli, Christoph I. Lee, Louise M. Henderson, Karla Kerlikowske +8 more

Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials

Research Square(2024)10.21203/rs.3.rs-3818932/v1
N/A
0DataRank · unranked
1 citations

Lanell M. Peterson, Jennifer M. Specht, Daniel S. Hippe, Alena Novakova-Jiresova, Jean H. Lee +6 more